Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial
COVID-19가 있는 중환자 중환자실 환자의 임상 상태, 사망률, 산화 스트레스 및 염증 지표에 대한 커큐민-피페인 보충제의 효과: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
addition
Administered
All participants
allocation sequence
ALT
anticipated
Anticoagulant
assigned
AST
baseline
Blinding
Blood oxygen saturation
C-reactive protein
Capsule
clinical
clinical status
Clinical symptoms
clinical trial
clinical trials
CLOCK
collected
color
conducted
congenital disorders
control group
coronavirus
COVID-19
creatinine
Critically ill
CRP
Curcumin
definitive diagnosis
Diseases
disorders
dissemination
double-blind
drug
Effect
Efficacy
element
eligible patient
enteral feeding
erythrocyte sedimentation
erythrocyte sedimentation rate
ESR
exclusion criteria
Factors
female
Fever
File
Hepatic insufficiency
hospital
ICU
ICU patient
ICU Patients
immune
include
inclusion criteria
independent
Inflammatory marker
intensive care
intensive care unit
Intervention
intervention group
investigators
Iran
kidney function marker
kidney function markers
labeling
LDH
liver
male
maltodextrin
marker
matching placebo
Medical Sciences
Mortality
mortality rate
normalization
number
Nurses
objective
odor
outcome
oxidative stress
oxygen
Pancreatitis
parameter
parenteral nutrition
participant
Participants
Patient
PCR test
performed
physician
Physicians
piperine
Placebo
placebo group
placebo-controlled
Primary outcome
protocol
provided
random
randomised
randomised controlled trial
Randomized
Randomized controlled trial
Randomly
receive
recruited
Registered
registration date
registration number
registry
renal
respiratory rate
Sample size
sealed
secondary outcome
Secondary outcomes
sedimentation rate
sensitivity
sequence
Seven
Sex
shape
status
Stratification
stratified block randomization
study participant
Study participants
Study protocol
supplementary material
Support
Tablet
Taste
temperature
the placebo group
title
Trial
Trial registration
turmeric
underlying disease
underlying diseases
university
ventilator
Version
Warfarin
website
weight
[DOI] 10.1186/s13063-021-05372-9 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-021-05372-9 PMC 바로가기 [Article Type] Letter